This Is Your Brain The Stone is a forum for contemporary philosophers and other thinkers on issues both timely and timeless. Despite rumors to the contrary, there are many ways in which the human brain isn’t all that fancy. Let’s compare it to the nervous system of a fruit fly. We study hard to get admitted to a top college to get a good job to get into the nursing home of our choice. But no. Erin Schell Neuroscientists understand the structural bases of some of these qualities. There’s another domain of unique human skills, and neuroscientists are learning a bit about how the brain pulls it off. Consider the following from J. Anxiety is secretive. Or: Compassion speaks with a slight accent. What is Gendler going on about? Symbols, metaphors, analogies, parables, synecdoche, figures of speech: we understand them. And we even understand that June isn’t literally busting out all over. A single part of the brain processes both physical and psychic pain. Or consider pain.
Cell Models For life all cells have basic needs. Cells have diverged in their structure and function to accommodate these survival requirements. Here are some KEY TERMS to help you think, explore and search for similarities and significant differences that have become the characteristics of eukaryote (animal, plant) and prokaryotic (bacteria) cells. Examples might be searching: eukaryote prokaryote reproduction or animal plant cell energy. Reproduction / cell division Energy trapping, storage and consumption Form / shape / structure Cell specialization Compartmentalization of cell functions Communication within and beyond the cell Cell / organism survival Parmesan, goat cheese and spinach flans I French Cooking for Dummies – Recipes, Parisian restaurants reviews… Here are some cute savory goat cheese and spinach flans really easy to make. They’re a perfect side dish for fish or meat and you can find thousands of variations. But you could use this savory flan recipe for starters or a light lunch as well, adding a salad on the side. This flan recipe features Parmesan, goat cheese and spinach. Once you’ve mastered these savory flans recipe you can let your imagination fly and try broccoli, cauliflower, carrots, eggplants or any vegetable you like with all sorts of cheeses. And if you feel adventurous and try different cheese and vegetables variations, don’t hesitate to share them with us in the comment section! Preparation time: 20 minutes – Cooking time: 20 minutes Ingredients (for 2 to 3 servings) 1 lb (450 g) of fresh spinach leaves2 1/2 oz (75 g) of goat cheese1 1/2 oz (45 g) of grated Parmesan2 eggs2 tablespoons of heavy cream2 teaspoons of butterSalt and pepper Instructions 1/ Wash and dry spinach leaves thoroughly. 4/ Dice goat cheese.
Deals Of The Week Looks For Quarters Under The Couch Cushions In today’s cash-constrained environment, drug markers are doing everything possible to limit the burn, while finding new sources of innovation. Hence this week’s news that Pfizer is teaming up with UCSF in an $85 million research collaboration (see below), as well as the respective emphasis at Roche and Novartis on “operational excellence” and “focused diversification”. This desire to wrest as much value out of available resources is also the driving force behind various big pharmas’ decisions to outlicense deprioritized assets, whether they are single-asset focused arrangements or spin-outs of actual whole departments. In the good old days, pharma didn’t have to think too hard about such measures. With abundant free cash flow and blockbuster projects these activities were a distraction deemed not worth the time and effort required.But like graduate students searching for additional cash underneath their sofa cushions, big pharmas can no longer afford not to monetize, monetize, monetize.
Doctor Suing Patients Over Negative Yelp Reviews Dr. Jay Pensler, a plastic surgeon in Chicago, isn’t happy with services such as Yelp. The doctor, unhappy about negative reviews his former patients posted on Yelp and Citysearch, is suing at least three of them for defamation. In court papers, Pensler, who calls himself a “well respected plastic surgeon,” says the women have “embarked on a malicious campaign to undermine and destroy” his personal reputation. On the review sites, many women claiming to be former patients offered descriptive and disturbing accounts of their encounters with the Chicago surgeon. On Yelp, another woman said her breasts looked like something out of a horror film. One of the women’s lawyers feels that the suits will be dismissed, but not until after each woman racks up thousands’ of dollars in legal fees. What do you think?
MacBook Air outperforms Windows netbooks and ultraportables | Business Center | From the Lab | Macworld We already know the 2010 MacBook Air models significantly improve on the previous generation in overall performance, but how do they stack up against Windows 7 laptops of similar size? Judged solely on performance, they dominate. With Windows 7 running on Apple’s featherweight machines, our test results indicate that the new Airs ran faster than all but one recent netbook or ultraportable from Windows PC vendors. The PCWorld Labs team used Apple's Boot Camp application to load Windows 7 on new 11-inch and 13-inch MacBook Air models. The 11-Inch MacBook Air: Floats Like a Netbook, Stings Like an Ultraportable First we tested a high-end 11-inch MacBook Air packing a 1.4GHz Core 2 Duo processor, 2GB of RAM, 128GB of flash storage and an Nvidia GeForce 320M integrated graphics chipset. Our WorldBench 6 software runs systems through a timed gauntlet of popular consumer applications such as Adobe Photoshop and Mozilla Firefox, compiles the results, and spits out an overall score.
I-SPY 2 study speeds up treatment for breast cancer A clinical trial that aims to speed up the study of new treatments for certain subtypes of breast cancer now has a designated study site at the Diane O'Connor Thompson Breast Center at the University of Colorado Hospital. This study, called I-SPY 2, (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2) will evaluate which medical treatments are most effective for different types of tumors. So-called "personalized medicine" in cancer is gaining ground as new drugs are developed that target known gene mutations. In the past, "it could take hundreds of thousands of dollars and several years to study a single drug", says Anthony Elias, MD, breast cancer program director and associate director for clinical research at the University of Colorado Cancer Center (UCCC). "HER2 and triple negative breast cancers are usually bad actors, but some of the ER positive breast cancers can also be aggressive," Elias says.
20 Things I Learned About Browsers and the Web Marketers unhappy with ‘biased, award-hunting’ digital agencies Six in ten marketers say they are unhappy with the work of their digital agencies, according to a new survey. The study was commissioned by Nucleus Digital Strategy. It said that in response to the question: “Are marketers satisfied with their current digital services supplier?”, 59% said no. The Digital State of the Nation survey was based on “82 candid interviews with senior Australian marketers”, said Nucleus. Marketers were also sceptical about the digital credentials of advertising agencies, with only 14% trusting their external digital marketing to ad agencies and 86% to specialist digital agencies. However, the report added: “There is a perception that digital agencies are failing to deliver strategies that effectively guide how the enterprise will deploy the digital channel. Some of the comments from marketers also suggest a difference of opinion between marketer and agency over social media. “We work in a low involvement commodity category. The report added:
Amgen receives approval for denosumab (Xgeva) in SRE for cancer At the NY Chemotherapy Foundation Symposium last week, several oncologists I spoke to said that a high price would be a significant barrier to use, so it would be reserved for those who do not respond or tolerate Zometa, or have poor renal function. Urologists would probably be more interested in Xgeva, since Zometa is an infusion product and they tend to refer patients to the oncologist for this. Xgeva, as a subcutaneous therapy, would therefore potentially be a more convenient option for urologists who have patients that progress to symptomatic metastatic prostate cancer. The other interesting thing I noticed from the data presented on Dmab at the NY Chemotherapy Meeting, was that while time to SRE was significantly improved with Xgeva compared to Zometa, there was no difference in survival between either therapy, as measured by both progression-free survival (PFS) and overall survival (OS). Another interesting item was data on a new PARP inhibitor, MK-4827, from Merck.
AVEO's RON antibody shows anti-tumor activity in human cancer xenografts AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preclinical data from AVEO's anti-RON antibody program which demonstrated the successful identification of antibodies with potent anti-tumor activity that demonstrated inhibition of the function of both wild type RON and the RONΔ160 variant, as well as a potential biomarker to identify tumors likely to respond to treatment with the anti-RON antibody. These data were presented yesterday in a late-breaker plenary presentation during the 22nd Annual Symposium of the European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research (EORTC-NCI-AACR) in Berlin, Germany. The lead antibodies from this program have been humanized for planned therapeutic development. RON (Recepteur d'Origine Nanatais, or MST1R) receptor tyrosine kinase is a member of the c-Met RTK family.